Jonathan R. Iredell

Investigating the role of excipients in mitigating surface adsorption, aggregation and structural degradation in liquid phage formulations

The race to produce therapeutically acceptable phages is driven by their rapid loss of infectivity, placing strain on laboratories, healthcare infrastructure and patients. Enhancing product shelf-life will alleviate this barrier to their upscaling and clinical application. We sys...